Proprietary AI analyst is now available
- Public Comps
- SI-BONE
SI-BONE Valuation Multiples
Discover revenue and EBITDA valuation multiples for SI-BONE and similar public comparables like Synektik, Beta Bionics, CeriBell, Barco and more.
SI-BONE Overview
About SI-BONE
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Founded
2008
HQ

Employees
559
Website
Financials (LTM)
EV
$647M
Valuation Multiples
Start free trialSI-BONE Financials
SI-BONE reported last 12-month revenue of $216M and EBITDA of $10M.
In the same LTM period, SI-BONE generated $171M in gross profit, $10M in EBITDA, and had net loss of ($19M).
Revenue (LTM)
SI-BONE P&L
In the most recent fiscal year, SI-BONE reported revenue of $201M and EBITDA of $9M.
SI-BONE is unprofitable as of last fiscal year, with gross margin of 80%, EBITDA margin of 4%, and net margin of (9%).
Financial data powered by Morningstar, Inc.
SI-BONE Stock Performance
SI-BONE has current market cap of $749M, and enterprise value of $647M.
Market Cap Evolution
SI-BONE's stock price is $16.88.
SI-BONE share price increased by 19.8% in the last 30 days, and decreased by 10.3% in the last year.
SI-BONE has an EPS (earnings per share) of $-0.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $647M | $749M | -2.6% | 19.8% | 33.6% | -10.3% | $-0.43 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSI-BONE Valuation Multiples
SI-BONE trades at 3.0x EV/Revenue multiple, and 62.1x EV/EBITDA.
EV / Revenue (LTM)
SI-BONE Financial Valuation Multiples
As of June 30, 2026, SI-BONE has market cap of $749M and EV of $647M.
SI-BONE has a P/E ratio of (38.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SI-BONE Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SI-BONE Margins & Growth Rates
SI-BONE grew revenue by 15% and EBITDA by 34% in the last fiscal year.
In the most recent fiscal year, SI-BONE reported gross margin of 80%, EBITDA margin of 4%, and net margin of (9%).
SI-BONE Margins
SI-BONE Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Operational KPIs
SI-BONE's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
SI-BONE's Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SI-BONE's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SI-BONE Competitors
SI-BONE competitors include Synektik, Beta Bionics, CeriBell, Barco, Oculis Holding, MedCap, SS Innovations, LifeTech Scientific, Advanced Medical Solutions Group and PHC Holdings.
Most SI-BONE public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.5x | 3.1x | 14.1x | 12.1x | |||
| 5.6x | 4.8x | (10.6x) | (8.5x) | |||
| 7.2x | 6.3x | (12.7x) | (11.9x) | |||
| 0.5x | 0.5x | 3.8x | 4.0x | |||
| 337.6x | 411.2x | (4.8x) | (5.0x) | |||
| 3.4x | 3.4x | 15.8x | 15.2x | |||
| 16.6x | - | (117.8x) | - | |||
| 3.1x | - | 14.5x | - | |||
This data is available for Pro users. Sign up to see all SI-BONE competitors and their valuation data. Start Free Trial | ||||||
SI-BONE VC Funding History
Before going public, SI-BONE raised $80M in total equity funding, across 3 rounds.
SI-BONE Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SI-BONE
| Who are competitors of SI-BONE? | SI-BONE main competitors include Synektik, Beta Bionics, CeriBell, Barco, Oculis Holding, MedCap, SS Innovations, LifeTech Scientific, Advanced Medical Solutions Group, PHC Holdings. |
See public comps similar to SI-BONE
Lists including SI-BONE
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.